PPG
53
-3
PCAR
56
11
PSA
35
15
FIS
48
2
MUR
49
2
CNP
70
2
NWSA
42
-18
IBM
67
3
XOM
57
-2
HP
36
2
EXPE
54
-2
IFF
48
-2
TDC
63
3
VFC
59
-2
IRM
47
3
VTR
63
6
MS
61
2
KR
49
4
DVA
47
-4
PG
20
-2
PPG
53
-3
PCAR
56
11
PSA
35
15
FIS
48
2
MUR
49
2
CNP
70
2
NWSA
42
-18
IBM
67
3
XOM
57
-2
HP
36
2
EXPE
54
-2
IFF
48
-2
TDC
63
3
VFC
59
-2
IRM
47
3
VTR
63
6
MS
61
2
KR
49
4
DVA
47
-4
PG
20
-2
Financhill
Back

Liquidia Corp. Vs. Apogee Therapeutics, Inc. Industry Stock Comparison

Buy
58

LQDA
Liquidia Corp.

Last Price:
$37.66
Seasonality Move:
-2.67%
Sell
44

APGE
Apogee Therapeutics, Inc.

Last Price:
$84.40
Seasonality Move:
-11.77%
Buy
58
Liquidia Corp. (LQDA) is a Buy

Is Liquidia Corp. a Buy, Sell or Hold?

  • The current Liquidia Corp. [LQDA] share price is $37.68. The Score for LQDA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • LQDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Apogee Therapeutics, Inc. (APGE) is a Sell

Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LQDA Stock Price Chart

What is Liquidia Corp.'s stock price today?

  • The Liquidia Corp. share price today is $37.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LQDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

APGE Stock Price Chart

What is Apogee Therapeutics, Inc.'s stock price today?

  • The Apogee Therapeutics, Inc. share price today is $84.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

LQDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.22 Buy
Relative Strength Index (14 RSI): 55.23 Buy
Chaikin Money Flow: 602499 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.8 - 37.9) Buy
Bollinger Bands (100): (30.93 - 39.55) Buy

APGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: 432550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 79.44) Buy
Bollinger Bands (100): (66.23 - 78.47) Buy

LQDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.46 Buy
20-day SMA: 36.68 Buy
50-day SMA: 37.5 Buy
200-day SMA: 28.34 Buy
8-day EMA: 36.79 Buy
20-day EMA: 36.41 Buy
50-day EMA: 36.15 Buy
200-day EMA: 29.68 Buy

APGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.91 Buy
20-day SMA: 75.21 Buy
50-day SMA: 71.36 Buy
200-day SMA: 57.28 Buy
8-day EMA: 80.37 Buy
20-day EMA: 76.41 Buy
50-day EMA: 73.33 Buy
200-day EMA: 61.58 Buy

Liquidia Corp. Earnings Growth & LQDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.12 per share, an increase next quarter of $1.29 per share, an increase this year of $3.20 per share, and an increase next year of $2.66 per share.

Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.

Liquidia Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):